Because there were few radiographic erosions and a large percentage of the cohort were on anti-TNF therapy, this study suggests that modalities more sensitive than plain radiographs will likely be necessary in the biologic era to evaluate the progression of RA. This evidence concerns the gene TNF and rheumatoid arthritis.